Final Programme
Location: Sofia, Bulgaria
“HOW TO MAKE IT GR8”
The program features speakers (expert doctors and scientists) from three continents: Europe, North America, and Asia.
It will make this conference truly global in scope. It will be an international celebration of collaboration and hope.
Friday, 17 April 2026
10.00-12.30 Arrival and registration, industry opens (time for parallel meetings and networking)
12.30-13.30 Lunch break
13.30-14.00 Opening ceremony
14.00-14.30 Opening keynote lecture – Novel Therapeutic Approaches and Clinical Guidelines for Aniridia – Dr Yoshinori Oie
14.30-16.00 Session 1: From bed to bench and back – stem cell research as new hope for aniridia patients
Panelists: Prof. Neil Lagali, Dr Jo Zhou
14.30-14.50 Latest update on stem cells, PAX6 and aniridia
Exploring developmental and postnatal PAX6 aniridia with spatial transcriptomics – Meri Vattulainen
Decoding epithelial homeostasis and stem cell renewal in the Aniridia Associated Keratopathy murine cornea by enriched high-resolution spatiotemporal single-cell transcriptomics – Dina Javidjam
14.50-15.10 Dissecting stem cell differentiation control in corneal development through multi-omics approaches – Dr Jo Zhou
15.10-15.30 Cornea organoids from aniridia-derived iPSC – Dulce Lima Cunha
15.30-16.00 Coffee break and Poster Session 1
16.00-17.30 Session 2: Young ophthalmologist, scientist, and patients presented posters
Title 1:Implantation of the keratoprosthesis in a child with congenital PAX6 aniridia and total corneal opacification (Polyakova E.U., Makhmutov V.U., Kalinnikov U.U., Utegusheva P.G.) – Ekaterina Polyakova
Title 2: Gene expression analysis of limbal epithelial cells from PAX6- aniridia patients – Elsa Berg
Title 3: Crystallins Beyond the Eye: A Potential PAX6-Dependent Mechanism Underlying Visual and Auditory Deficits in Aniridia – Israa Sefawi
Title 4: Congenital Aniridia: Organisational Models of Care and Quality of Life Outcomes – Marfuga Oteuliyeva
Title 5: Congenital Aniridia In A One-Year-Old Child: Clinical Findings And Molecular Confirmation – Doroteya Yordanova, Milena Stoyanova
Introduction of Prof.Barbara Käsmann-Kellner Award by Barbara Poli. Announcement of the recipient.
17.30-18.30 Session 3: Facilitating the Quality of Life – Multilevel Perspective
Panelists: Dr Sabrina Vaccaro, Dr Huban Atilla, Daniel Egido
17.30-17.50 Unmet needs of aniridia patients in the everyday clinical practice – Dr Huban Atilla
17.50-18.10 The patient perspective – Daniel Egido
18.10-18.30 Panel discussion: How to improve?
Dr. Sabrina Vaccaro, Dr. Huban Atila, Daniel Egido, James Buller, Katherine Atkinson, Prof. Christin Grupcheva
18.30 Closure of DAY ONE
19.00 Networking – Earth and Man National Museum
Saturday, 18 April
08.00-18.00 Registration and welcome
08.30-10.00 Session 4: The new perspectives in treatment of Glaucoma
Panelists: Dominique Bremond-Gignac, Peter Netland, Alejandra Daruich
08.30-08.50 The role of lasers – Prof. Christina Grupcheva
08.50-09.10 PAX6-related glaucoma. Anti-glaucoma medication and MIGS Preserflo – Prof. Dominique Bremond-Gignac
09.10-09.30 MIGS Xen and When nothing helps… – Prof. Peter Netland
09.30-9.50 Discussion
09.50-10.30 Coffee break and Poster Session 2
10.30-12.00 Session 5: The new perspectives in treatment of Dry eye
Panelists: Prof. Nora Szentmary, Prof. Maria Del Carmen Acosta, Prof. Christina Grupcheva
10.30-10.50 Inflammation matters – Prof. Christina Grupcheva
10.50-11.10 Current Understanding of Corneal Sensory Nerve Functionality in Aniridia – Prof. Maria Del Carmen Acosta
11.10-11.30 All is a vicious circle – Prof. Nora Szentmary
11.30-12.00 The “best” artificial tears – patient’s perspective – discussion with patients’ involvement
12.00-12.20 The long way to success treating ocular surface and glaucoma (in collaboration with SANTEN) – Prof. Christina Grupcheva
12.20–12.30 Gratitude to sponsors and supporters
12.30-13.00 Progress on aniridia research and therapies for aniridia-associated keratopathy – Neil Lagali
13.00-13.30 Packed lunch
13.30-14.00 Keynote lecture of the BSO “Genetic testing and consultations as а standard of care for people with rare eye disease“ – Dr Petia Stratieva (Retina Bulgaria)
14.00-15.30 Session 6: Facilitating the quality of life – the Multilevel Perspective
Panelists: Dr Sabrina Vaccaro, Prof. Peter Netland, Dr Yoshinori Oie
14.00-14.20 How to assess quality of life – European perspective – Dr Sabrina Vaccaro
14.20-14.40 How to assess quality of life – US perspective – Prof. Peter Netland
14.40-15.00 How to assess quality of life – Asian perspective – Dr Yoshinori Oie
15.00-15.30 How to achieve quality of life – Patient’s perspective – Katherine Atkinson, Daniel Egido,
15.30-16.00 Coffee break and Poster Session 3
16.00-17.30 Session 7: The Retina and Beyond
Panelists: Prof. Dominique Bremond-Gignac, Prof. Alejandra Daruich
16.00-16.30 Retina in aniridia – Prof. Alejandra Daruich
16.30-17.00 Beyond the Eye: Pax6 Haploinsufficiency and its impact on Cortical and Neuroendocrine Function – Jim Lauderdale
17.00-17.30 Beyond the Iris: Managing the Full Spectrum of WAGR Syndrome (Recording) – Kelly Trout, International WAGR Syndrome Association (IWSA)
17.30-18.00 Interdisciplinary approach for better care – round table
Panelists: Prof. Nora Szentmary, Dr Yoshinori Oie, Prof. Huban Atila
18.00-18.30 Session 8 Free presentations
Title 1: Clinical-genetic forms of congenital aniridia in Bulgaria – Anna Popova
Title 2: Restoring PAX6 expression via CRISPR activation: a road towards transparency – Catia Mio
18.30 Closure of DAY TWO
19.00 Networking – Introduction of Bulgarian folk culture, traditional remedies, and herbs
Sunday, 19 April
08.00-13.00 Registration and welcome
08.30-11.00 Session 9: New diagnostic approaches and therapeutic innovations
Panelists: Prof. Neil Lagali, Assoc. Prof. Jim Lauderdale, Prof Peter Netland
09.00-09.30 Follow-up of children with congenital aniridia – an interdisciplinary approach – Erlend Landsend (Recording)
09.30-10.00 Diagnostics in aniridia – Fabian Fries
10.00-10.30 Coffee break and Networking
10.30–11.00 Targeting insulin receptor substrate-1 delays disease progression in a murine model of aniridia-associated keratopathy – Ava Dashti
11.00-11.30 Antisense Oligonucleotide Eye Drops Against IRS-1 to Treat Pathological Corneal Neovascularisation in Aniridia-Associated Keratopathy – Mert Mestanoglu
11.30-12.00 Patient-scientist discussion and questions
All speakers, panelists and patient associations/patients and families
12.00-13.00 Closing remarks, Networking and Packed lunch
If you have questions, please do not hesitate to contact us: 8th@eac-2026.com
